Anti-Ohr Pharmaceutical Inc Institutional Investors Sentiment Runs Low in Q1 2018

June 18, 2018 - By reb123z

OHR Pharmaceutical, Inc. (NASDAQ:OHRP) Logo

Sentiment for Ohr Pharmaceutical Inc (NASDAQ:OHRP)

Ohr Pharmaceutical Inc (NASDAQ:OHRP) institutional sentiment decreased to 0.82 in 2018 Q1. Its down -0.63, from 1.45 in 2017Q4. The ratio is negative, as 14 funds increased and started new positions, while 17 decreased and sold their stakes in Ohr Pharmaceutical Inc. The funds in our partner’s database now own: 5.09 million shares, down from 5.70 million shares in 2017Q4. Also, the number of funds holding Ohr Pharmaceutical Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 9 Reduced: 8 Increased: 7 New Position: 7.

OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The company has market cap of $13.54 million. The Company’s lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes. It currently has negative earnings. The firm is evaluating Squalamine, which completed Phase II clinical trials for the treatment of retinal diseases, including wet-AMD, proliferative diabetic retinopathy, and retinal vein occlusion.

The stock decreased 3.93% or $0.0098 during the last trading session, reaching $0.2398. About 706,102 shares traded or 13.88% up from the average. OHR Pharmaceutical, Inc. (NASDAQ:OHRP) has declined 66.39% since June 18, 2017 and is downtrending. It has underperformed by 78.96% the S&P500.

Garrison Bradford & Associates Inc holds 0.09% of its portfolio in OHR Pharmaceutical, Inc. for 482,200 shares. Leisure Capital Management owns 64,251 shares or 0.01% of their US portfolio. Moreover, Balyasny Asset Management Llc has 0% invested in the company for 24,590 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 43,759 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: